source
- Bristol Myers reports Krazati confirmatory trial fails in colorectal cancerBristol Myers Squibb disclosed that the confirmatory study of its investigational drug Krazati in combination with an EGFR inhibitor did not achieve its primary efficacy endpoints in patients with…
- Roche partners with Otsuka's Astex in $25 million deal to strengthen breast cancer pipelineRoche's Genentech subsidiary has signed a collaboration with Astex Pharmaceuticals, a unit of Otsuka, that includes a $25 million upfront payment. The partnership is an early‑stage effort aimed at…